PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.\', \'Department of Virology, Toyama Institute of Healthgrid.417376.0, Toyama, Japan.\', \'Toyama City Hospitalgrid.417233.0, Toyama, Japan.\', \'Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.\', \'Laboratory of Virus Control, Center for Infectious Disease Education and Research (CiDER), Osaka Universitygrid.136593.b, Osaka, Japan.\', \'Laboratory of Virus Control, Research Institute for Microbial Diseases (RIMD), Osaka Universitygrid.136593.b, Osaka, Japan.\', \'Toyama Institute of Healthgrid.417376.0, Toyama, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/Spectrum.00560-21
?:doi
?:hasPublicationType
?:journal
  • Microbiology spectrum
is ?:pmid of
?:pmid
?:pmid
  • 34851163
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.814
?:rankingScore_hIndex
  • 21
?:title
  • Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34851163>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34851163>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all